Breaking News

QPharma Appoints Medical Officer

May 17, 2013

Shaw to oversee QLaunch platform

Dr. Peter J. Shaw has been appointed chief medical officer at QPharma. Dr. Shaw will oversee numerous initiatives, including the company’s QLaunch platform designed to maximize compliance and commercial effectiveness of life science product launches.
 
Dr. Shaw previously served as president and chief operating officer of MD Mindset, LLC, a pharma sales force and marketing firm, with responsibility for company operations, product development, and business development. Prior to this, he was president and founder of London-based Metamorph Doctors, Inc., which was established to train medical sales professionals to communicate with physicians more effectively.
 
“Dr. Shaw’s breadth of experience as a physician, executive, and respected key opinion leader in the pharmaceutical industry speaks for itself,” said QPharma president and chief executive officer, Patrick P. Den Boer. “I am confident that he will bring outstanding value to our clients as a core member of our executive leadership team.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks